Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity

Juliet A. Emamaullee, Shaheed Merani, Christian P. Larsen, A. M.James Shapiro

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity'. Together they form a unique fingerprint.

Medicine & Life Sciences